NeoPlas Innovation - Company Review
NeoPlas Innovation - Company ReviewSummary
NeoPlas Innovation (NeoPlas) is a healthcare service provider that offers treatment for patients affected with cancer. The hospital provides treatment to patients with renal cancer, malignant fibrous histiocytoma, osteosarcoma, melanoma, colon cancer, pancreatic carcinoma, mesothelioma, chondrosarcoma and desmoplastic small round cell tumor, among others. It offers long-term survival rates for most malignancies cancer. NeoPlas conducts medical research and development programs. The hospital carries out optimizing the combination of cancer treatment with traditional chemotherapy and other existing therapies. Its lovastatin impede tumor-induced angiogenesis in a melanoma model in mice; and also provides treatment for animals. NeoPlas is headquartered in Franklin, Tennessee, the US.
This comprehensive company report of NeoPlas Innovation provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.